<DOC>
	<DOC>NCT01850420</DOC>
	<brief_summary>This is a randomized, double-blind, placebo-controlled, 16-week study designed to evaluate the hypothesis that tissue-resident herpes virus may be causally related to fibromyalgia symptoms or recurrence. IMC-1 is a combination treatment that is designed to suppress this suspected virus and thus alleviate fibromyalgia symptoms.</brief_summary>
	<brief_title>A Study of IMC-1 In Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>Diagnosis of fibromyalgia English speaker Rheumatologic diseases Bipolar disease, OCD, severe anxiety, schizophrenia Systemic infection, severe cardiac disease, chronic steroid usage chronic opioid usage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>fibromyalgia</keyword>
	<keyword>Myofascial</keyword>
</DOC>